Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Department of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan.
J Thromb Thrombolysis. 2023 Jul;56(1):103-110. doi: 10.1007/s11239-023-02816-8. Epub 2023 May 2.
Implantable loop recorders (ILRs) are useful for the detection of atrial fibrillation (AF) in patients with cryptogenic stroke (CS). P-wave terminal force in lead V (PTFV) is associated with AF detection; however, data on the association between PTFV and AF detection using ILRs in patients with CS are limited. Consecutive patients with CS with implanted ILRs from September 2016 to September 2020 at eight hospitals in Japan were studied. PTFV was calculated by 12-lead ECG before ILRs implantation. An abnormal PTFV was defined as ≥ 4.0 mV × ms. The AF burden was calculated as a proportion based on the duration of AF to the total monitoring period. The outcomes included AF detection and large AF burden, which was defined as ≥ 0.5% of the overall AF burden. Of 321 patients (median age, 71 years; male, 62%), AF was detected in 106 patients (33%) during the median follow-up period of 636 days (interquartile range [IQR], 436-860 days). The median time from ILRs implantation to AF detection was 73 days (IQR, 14-299 days). An abnormal PTFV was independently associated with AF detection (adjusted hazard ratio, 1.71; 95% confidence interval [CI], 1.00-2.90). An abnormal PTFV was also independently associated with a large AF burden (adjusted odds ratio, 4.70; 95% CI, 2.50-8.80). In patients with CS with implanted ILRs, an abnormal PTFV is associated with both AF detection and a large AF burden.Clinical Trial Registration Information: UMIN Clinical Trials Registry 000044366.
植入式循环记录器 (ILR) 可用于检测隐源性卒中 (CS) 患者的心房颤动 (AF)。P 波终末电势在导联 V (PTFV) 与 AF 检测相关;然而,关于 CS 患者使用 ILR 检测 PTFV 与 AF 之间的关联的数据有限。研究了 2016 年 9 月至 2020 年 9 月期间日本 8 家医院植入 ILR 的连续 CS 患者。在植入 ILR 之前,通过 12 导联心电图计算 PTFV。异常 PTFV 定义为≥4.0 mV × ms。AF 负荷根据 AF 持续时间与总监测期的比例计算。结果包括 AF 检测和大 AF 负荷,定义为总 AF 负荷的≥0.5%。在 321 例患者(中位年龄 71 岁,男性 62%)中,106 例(33%)在中位随访 636 天(四分位距 [IQR],436-860 天)期间检测到 AF。从 ILR 植入到 AF 检测的中位时间为 73 天(IQR,14-299 天)。异常 PTFV 与 AF 检测独立相关(校正后的危险比,1.71;95%置信区间 [CI],1.00-2.90)。异常 PTFV 也与大 AF 负荷独立相关(校正优势比,4.70;95%CI,2.50-8.80)。在植入 ILR 的 CS 患者中,异常 PTFV 与 AF 检测和大 AF 负荷均相关。临床试验注册信息:UMIN 临床研究注册 000044366。